Albany, NY -- (SBWIRE) -- 05/20/2014 -- Cameroon Pharmaceuticals & Healthcare Report
Cameroon will continue to be one of the least attractive countries in the Middle East and Africa region considering that healthcare provision is not one of the government's key focuses. Consequently, poor healthcare services coupled with other risks such as rampant corruption, approval delays and low percapita healthcare and pharmaceutical expenditure meant little growth opportunities for pharmaceutical investors.
Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/the-pharmaceutical-market-cameroon
Headline Expenditure Projections
Pharmaceuticals: XAF134.37bn (US$260mn) in 2012 to XAF144.07bn (US$270mn) in 2013; +7.2% in local currency terms and +5.5% in US dollar terms.
Healthcare: XAF698.97bn (US$1.35bn) in 2012 to XAF745.18bn (US$1.42bn) in 2013; +6.6% in local currency terms and 4.9% in US dollar terms.
Cameroon's Pharmaceutical Risk/Reward Rating (RRR) score for Q213 is unchanged from the previous quarter. This is also the case for all other countries in BMI's proprietary system that ranks pharmaceutical markets according to attractiveness to multinational drugmakers. A minor re-weighting of one of the RRR components is being implemented to improve the tool, and the adjusted scores for all markets will be published in the Q313 updates of the Pharmaceuticals & Healthcare reports. Cameroon has a RRR score of 31.5 out of 100, making it the 27th most attractive pharmaceutical market in the Middle East and Africa.
To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/198479
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Contents
BMI Industry View7
Pharmaceutical Market Forecast12
Table: Pharmaceutical Sales Indicators, 2009-201713
Key Growth Factors - Healthcare14
Table: Healthcare Expenditure Indicators, 2009-201717
Table: Healthcare Governmental Indicators, 2009-201718
Table: Healthcare Private Indicators, 2009-201718
Industry Risk Reward Ratings22
To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis/198479
Table: MEA Pharmaceuticals And Healthcare Risk/Reward Ratings, Q21322
Industry And Company Developments28
Table: Cameroon\'s Population By Age Group, 1990-2020 (\'000)31
Table: Cameroon\'s Population By Age Group, 1990-2020 (% of total)31
Table: Cameroon\'s Key Population Ratios, 1990-202032
Table: Cameroon\'s Rural And Urban Population, 1990-202033
Office: United States
90 State Street, Suite 700
Albany, NY 12207
Toll Free: 866-997-4948